SPONSOR
Jonsson Comprehensive Cancer Center
Total Trials
9
Recruiting
9
Phases
Phase 1, Phase 2
Conditions studied: Prostate Cancer (CRPC)GlioblastomaGlioblastoma, IDH-WildtypeGliosarcomaRecurrent Glioblastoma, IDH-WildtypeRecurrent GliosarcomaResectable GlioblastomaProstate AdenocarcinomaStage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIC Prostate Cancer AJCC v8
Jonsson Comprehensive Cancer Center is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Prostate Cancer (CRPC), Glioblastoma, Glioblastoma, IDH-Wildtype, Gliosarcoma.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Jonsson Comprehensive Cancer Center
How many clinical trials has Jonsson Comprehensive Cancer Center sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by Jonsson Comprehensive Cancer Center, of which 9 are actively recruiting participants. These trials cover conditions including Prostate Cancer (CRPC), Glioblastoma, Glioblastoma, IDH-Wildtype. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Jonsson Comprehensive Cancer Center research focus on?
Jonsson Comprehensive Cancer Center clinical trials span Prostate Cancer (CRPC), Glioblastoma, Glioblastoma, IDH-Wildtype, Gliosarcoma, Recurrent Glioblastoma, IDH-Wildtype, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Jonsson Comprehensive Cancer Center clinical trial?
To participate in a Jonsson Comprehensive Cancer Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Jonsson Comprehensive Cancer Center trials with current recruitment status updated daily.
Clinical Trials by Jonsson Comprehensive Cancer Center
NCT07077239
Recruiting
Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity
Prostate Cancer (CRPC)
NCT07089641 Phase 1
Recruiting
ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
Glioblastoma
NCT04945642
Recruiting
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
Prostate Adenocarcinoma
NCT04553770 Phase 2
Recruiting
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
Early-stage Breast Cancer
NCT06064682
Recruiting
An Organoid-based Functional Precision Medicine Trial in Osteosarcoma
Osteosarcoma
NCT06376565
Recruiting
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
Colorectal Carcinoma
NCT06980077 Phase 2
Recruiting
Ivonescimab for the Treatment of Thymic Cancer
Thymus Carcinoma
NCT06436612 Phase 2
Recruiting
Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdominopelvic Sarcomas (MARS Trial)
Abdominopelvic Sarcomas
NCT04453072
Recruiting
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant
Obesity
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology